Drug	Gene	Variant	Genotype	Clinical_relevance	Category	ITA
Amisulpride	MC4R	rs489693	A/A	may have an increased likelihood of weight gain and hypertriglyceridemia when taking amisulpride	yellow	Possibile incremento ponderale e dei trigliceridi
Citalopram	SLC6A4	LS allele	LS	may have decreased response	yellow	Possibile riduzione dell'efficacia clinica
Citalopram	SLC6A4	LS allele	SS	may have decreased response and increased risk for side effects	red	Riduzione dell'efficacia clinica e aumento del rischio di effetti collaterali
Citalopram	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Citalopram	HTR2A	rs7997012	G/G	may be less likely to have improvement in symptoms	yellow	Possibile riduzione dell'efficacia clinica
Escitalopram	SLC6A4	LS allele	SS	may have a decreased response or decreased improvement based on HAMD score reduction	yellow	Possibile riduzione dell'efficacia clinica
Fluoxetine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Fluoxetine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Mirtazapine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Mirtazapine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Paroxetine	HTR1A	rs6295	CG	may have an reduced response at 4 weeks of treatment	yellow	Possibile riduzione dell'efficacia clinica
Paroxetine	HTR1A	rs6295	CC	may have an reduced response at 4 weeks of treatment	yellow	Possibile riduzione dell'efficacia clinica
Paroxetine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Paroxetine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Venlafaxine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
Venlafaxine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow	Possibile riduzione dell'efficacia clinica
